Bob Lilly had been a staple along the Dallas Cowboys defensive line for over a decade, and he was hoping that Super Bowl VI would be his time to finally win a championship. The Cowboys had fallen ...

Eli Lilly and Company LLY will release its fourth-quarter financial results, before the opening bell, on Thursday, Feb. 6, 2025. Analysts expect the Indianapolis, Indiana-based company to report ...

24.75 x 59.87 in. (62.9 x 152.1 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as the drugmaker struggled to forecast demand for its popular weight-loss and diabetes shots for the second quarter ...

Poster icon, inspirational figure, messenger for Rastafarianism, forever young hero… Bob Marley (born February 6, 1945; died May 11, 1981) was all those things and more. Musically, however ...

Copyright 2025 The Associated Press. All Rights Reserved. A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis on April 26, 2017 ...

Eli Lilly recently updated Q4 revenue guidance, and sales are expected to come in lower than previously anticipated. While this could suggest the company is experiencing sluggish or plateauing ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December scripts boost. The stock is attractively valued at current levels.

Lilly should be in position to dominate the market for so-called “incretin” drugs that treat diabetes, obesity and metabolic disease. Zepbound beat its immediate rival, Novo Nordisk’s Wegovy, in a ...